Fujifilm uses AI software to identify bone trauma

Published: 2-Aug-2022

Partnership with GLEAMER integrates artificial intelligence into X-ray imaging systems at the point of care

Fujifilm has partnered with medtech company, GLEAMER, to integrate artificial intelligence into its X-ray imaging systems.

BoneView is a revolutionary AI software designed to assist radiologists and emergency clinicians in the diagnosis of skeletal fractures.

It uses advanced algorithms to detect and localise lesions on X-rays – graphically highlighting areas of interest – before submitting the images to radiologists for validation.

Fujifilm X-ray systems are equipped with a new image processing box, EX-Mobile, enabling to connect with BoneView software.

Results are available within 30 seconds at the point of care, providing healthcare professionals with additional support to help improve patient management.

The user-friendly software can be seamlessly integrated into Fujifilm’s comprehensive X-ray modality line-up, making it perfectly suited to small or remote clinics, pop-up medical centres, nursing homes, and large multi-function institutions.

This will aid medical staff in the rapid identification of patients with suspected fractures, triaging them for further investigation to ease workflows and enhance patient care pathways.

A clinical trial involving appendicular skeletal fractures found that BoneView reduced the number of false positives by 41.9 %, and improved fracture detection sensitivity and specificity.

These results are supported by another study involving additional anatomical locations, where AI assistance reduced radiograph reading times by 6.3 seconds per patient.

Richard Cahalane, product manager for digital modalities at FUJIFILM Europe, said: “It is very exciting to be part of this partnership.

“BoneView is an extraordinary tool that will assist busy radiographers, radiologists, and clinicians to better manage patients at the point of care, adding value for both staff and the patients.”

Christian Allouche, chief executive at GLEAMER, added: “Having Fujifilm on board has been crucial in the development of this product, and to get it in front of the clinicians that need it.

“AI technologies are becoming increasingly established in the medical sector, and really proving their value.

“Any medical innovation is about improving the care of the patient, and BoneView promises to do just that.”

You may also like